Chronic focal epilepsy is associated with synaptic plasticity and growth of new connections. Brain-derived neurotrophic factor (BDNF) is associated with each of these processes in normal brain and shows acute up-regulation in models of generalized epilepsy. Here, using an experimental model of focal epilepsy, we show persistent up-regulation of BDNF mRNA, independent of that of other growth factors, in association with the development and persistence of chronic seizures. In situ hybridization histochemistry revealed that rats perfused within 2-3 days after seizure onset had widespread increases in BDNF mRNA levels in the neocortex. Rats perfused at later times, however, showed focal up-regulation of BDNF mRNA at the injection site and down-regulation in a surrounding cortical zone. Nerve growth factor and neurotrophin-3 mRNAs were not significantly altered. These reciprocal changes in BDNF gene expression in the epileptic focus and the cortical surround may contribute to plastic changes in epileptic neuronal circuits that accompany the transition from acute to chronic epilepsy. BDNF down-regulation in the surround is likely to be associated with the inhibitory surround that hampers seizure spread, but facilitates the persistence of a chronic epileptic focus.
Introduction
Epileptogenesis is characterized by long-lasting changes in neuronal excitability. In many experimental models of epilepsy, increased excitability is accompanied by corresponding alterations in gene expression for neuroactive molecules. Of particular interest is the expression of neurotrophin genes which are involved in diverse forms of neural plasticity (Gall, 1993; Lindholm et al., 1994; Lo, 1995; Thoenen, 1995; Patterson et al., 1996) . In various models of epilepsy involving the limbic system -e.g. hippocampal kindling, hippocampal hilus lesion, quinolinic acid injection in the hippocampus or systemic administration of kainic acid -mRNAs for brainderived neurotrophic factor (BDNF) and nerve growth factor (NGF) are markedly up-regulated (Gall and Isackson, 1989; Ernfors et al., 1991; Isackson et al., 1991; Dugich-Djordjevic et al., 1992; Rocamora et al., 1992; Humpel et al., 1993; Lauterborn et al., 1994; Schmidt-Kastner et al., 1996) . Most of these results are characterized by a rapid onset, a transient timecourse lasting from a few hours to ∼12 h, and a widespread areal distribution bilaterally across the limbic system and neocortex. These results demonstrate the activity-dependent character of neurotrophin gene expression in epilepsy, but do not address changes occurring during the development and persistence of chronic epilepsy, especially that of focal origin.
In the neocortex, certain of the neurotrophins, notably BDNF and neurotrophin-3 (NT-3) inf luence dendritic growth (McAllister et al., 1997) , and activity-dependent inf luences on inhibitor y interneurons are mediated by a BDNF-dependent mechanism (Rutherford et al., 1997) . Disturbance of the balance of excitation and inhibition in neocortical epileptogenic foci is a major determinant of seizure activity. There is also evidence that axons of neurons may undergo sprouting in chronically injured cortical foci that become epileptogenic (Salin et al., 1995) , but the mechanisms governing this and the role of neurotrophins are not yet clear. Using in situ hybridization histochemistry, the present study mapped distribution of BDNF, NGF and NT-3 mRNAs in a model of chronic recurrent focal seizures induced by injection of tetanus toxin (TT) in rat motor cortex (Mellanby et al., 1977; Jefferys et al., 1995) . The TT model of epilepsy offers several advantages over other seizure models: it does not induce observable cell loss (Kessler and Markowitsch, 1983; Jefferys et al., 1992) ; the chronic and recurrent character of TT-induced seizures resembles that of clinical seizures in human; animals require little manipulation after TT injection and therefore, nonspecific effects induced by surgery, stress or anesthesia can be minimized. In a previous study, we showed that TT injection sets up a focus of altered gene expression for a number of molecules involved in the glutamatergic and GABAergic systems, surrounded by a zone of reciprocal changes . This surrounding zone appears to ref lect the inhibitory surround which serves to constrain an epileptic focus and maintain it as a source of recurrent seizure activity in clinical focal epilepsy (Prince and Wilder, 1967) . The changes are now shown to be also accompanied by reciprocal alterations in BDNF gene expression which may promote maladaptive changes such as axon sprouting which would further maintain seizure activity.
The results have been reported previously in abstract form .
Materials and Methods

Surgery and Tetanus Toxin Injection
Twenty-four Wistar rats of either sex, 6-12 weeks old and weighing 150-290 g, were injected with TT (1 with 20 ng, 16 each with 25 ng and 7 each with 35 ng). Of these, seven (3 with 35 ng TT, 3 with 25 ng TT and 1 with 20 ng TT) died of generalized seizures on postoperative days 4-11, and were excluded from further analysis. Four of the rats (2 injected with 35 ng and 2 with 25 ng TT) were perfused on postoperative day 5 because of severe seizure activity. Six of the remaining rats were perfused on postoperative day 7 and the other seven on postoperative day 14. Of these, all but two (perfused on day 7) had seizures.
Detailed protocols for surgery and injection of TT or saline have been described elsewhere . The rats were anesthetized with ketamine (100-150 mg/kg body wt, i.m., plus 25 mg/kg additional doses when necessary). The skull was opened over the motor cortex on one side. The dura mater was left intact. The representation of forelimb digit and wrist movements in the motor cortex was identified by intracortical microstimulation (ICMS; 30 ms trains consisting of cathodal pulses of 0.2 ms width at a rate of 300/s; Asanuma and Sakata, 1967) , using a low-impedance (<1 MΩ at 1 kHz) tungsten microelectrode inserted through the dura mater into the cortex (1.6-1.7 mm deep to the dural surface). The locus from which clear movements of the contralateral wrist and/or digits could be elicited by low-threshold ICMS (<30 µA) was almost invariably located 0.8-1.1 mm rostral to bregma, 2.7-3.0 mm lateral to the midline and 1.6-1.8 mm deep to the dural surface. Tetanus toxin (List Biologicals, Campbell, CA), diluted in 0.3-0.8 µl 0.9% NaCl was injected in the above ICMS site at a depth of 1.2 mm from the dural surface. The glass micropipettes used for TT injection had external tip diameters of 20-30 µm. The dosage of 20-35 ng TT was determined by results from pilot experiments in which 19 rats received 2-13 ng TT and showed no signs of seizure activity .
After the injection, the animals were monitored daily for epileptic behavior. They were finally anesthetized with Nembutal (80 mg/kg) and transcardially perfused with saline, followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The brains were removed, postfixed at 4°C in the same fixative for 3-6 h and cryoprotected with 30% sucrose. Frozen sections 40 µm thick were cut on a sliding microtome and sections were collected in phosphate-buffered 4% paraformaldehyde (pH 7.4) for in situ hybridization histochemistry.
Eight control rats of similar body weight were injected with 0.8 µl 0.9% NaCl in the motor cortex and were perfused on postoperative day 5 (n = 2), 7 (n = 3) or 14 (n = 3). Two other control rats were perfused under Nembutal anesthesia without any prior surgical operation.
In Situ Hybridization Histochemistry
Free-f loating sections were rinsed twice in 0.1 M phosphate-buffered glycine (0.75%, pH 7.4) followed by a wash in 0.1 M phosphate buffer (pH 7.4). They were then digested with proteinase K (0.5 µg/ml 0.1 M Tris-HCl buffer, pH 8.0, containing 0.05 M ethylenediaminetetraacetic acid, EDTA) for 8-10 min at room temperature. Digestion was stopped with 0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0. Following two washes in 2× SSC (saline/sodium citrate, pH 7.0; 1× SSC consists of 0.88% NaCl and 0.44% Na 3 C 6 H 5 O 7 .2H 2 O), the sections were incubated for 1 h at 60°C in hybridization buffer consisting of 50% deionized formamide, 10% dextran sulfate, 5% 2× SSC, 0.9% Ficoll, 0.9% polyvinyl pyrolidone, 0.9% bovine serum albumin. Just before use, 0.3 mg/ml of herring sperm DNA, 0.15 mg/ml of wheat germ transfer RNA and 40 mM/ml of dithiothreitol were added. Sections were then transferred to new hybridization buffer containing one of the following cRNA probes.
All probes were transcription-labeled with [ 35 S]UTP. The 800 base cRNA probes for NGF were transcribed from a genomic clone of rat NGF (pBSrNGF; see Scarisbrick et al., 1993 for more details). The 384 base cRNA probes for BDNF were transcribed from rat BDNF genomic DNA (pBSr1112-8; Isackson et al., 1991) . cRNA probes for NT-3 were transcribed from a region of rat genomic DNA encoding bases 481-873 of rat NT-3 gene. All DNAs were cloned into the pBKS(+) BlueScript vector and were linearized before transcription labeling. Transcription with T3 RNA polymerase produced sense (for NGF) or antisense probes (for BDNF and NT-3), and transcription with T7 RNA polymerase produced antisense (for NGF) or sense probes (for BDNF and NT-3). The specificity of these probes for the respective mRNAs and the lack of cross-reactivity between probes have been tested in a previous study under similar hybridization conditions (Scarisbrick et al., 1993) . All probes were diluted to a final concentration of 1.5 × 10 7 c.p.m./ml hybridization buffer. All had similar G/C ratios and specific activities.
A fter 20-36 h incubation at 60°C, the sections were sequentially washed in the following solutions (except for ribonuclease A, all contained 5 mM dithiothreitol /ml): 4× SSC, 60°C, twice, 20 min each; ribonuclease A (0.02 mg/ml in 0.01 M Tris-HCl buffer, pH 8.0, and 1 mM EDTA, 2.9% NaCl) at 45°C, 30 min; 2× SSC, room temperature, twice, 30 min each; 0.5× SSC, 60°C, twice, 30 min each; 0.1× SSC, room temperature, twice, 20 min each. Sections were then mounted on chrome alum-gelatin-coated glass slides, air-dried, placed in contact with Amersham β-Max film and exposed for 2-9 days. After development of the film, the sections were coated with Kodak NTB2 emulsion and exposed at 4°C for 4-8 weeks. Autoradiograms were then developed in Kodak D-19, counterstained with cresyl violet, dehydrated in graded alcohols, cleared in xylene and coverslipped in DPX.
In each animal, a series of sections through the whole brain was also mounted and stained with thionin.
Sense controls revealed no labeling above background levels.
Data Analysis
Sections labeled by in situ hybridization histochemistry were examined for differences between the ipsi-and contralateral hemispheres and between different cortical and subcortical regions in individual rats. Differences were then compared across animals. Optical density measurements were made of autoradiograms, using a computer-assisted image analysis system (MCID, Imaging Research Inc., St Catharine's, Ontario), as described previously . The relative optical density values were converted to measures of radioactivity (µCi/g) by reference to a set of 14 C standards (Amersham) exposed on the same sheet of film, and then compared between the two hemispheres and across cortical areas.
For semi-quantitative analysis of changes in gene expression across different cortical areas, sampling was made in rectangles measuring 0.021-0.026 mm 2 , from cortical areas which showed potential changes in gene expression and from homotopic cortical areas on the contralateral side. For each cortical area, 24-48 samples from 2-4 sections and extending across each of the cortical layers were collected from each animal. Background radioactivity was determined for each section by averaging six samples from an image area outside the autoradiograms and adjacent to the sampled cortical area. Background was subtracted from all readings from all cortical areas before a mean value of radioactivity for each cortical area of individual animals was calculated. Student's paired t-test was performed to assess the significance of differences in gene expression in homotopic areas on the two sides for each control and experimental animal group. A percentage change in gene expression for a cortical area was then generated by dividing the mean radioactivity reading from the ipsilateral side by the mean reading from the corresponding cortical area on the contralateral side. A grand mean of percentage change was then computed by averaging means from individual animals of the same survival group.
The homotopic area on the contralateral side was used as a control. This was based on the obser vation that cortical areas on the side contralateral to TT injection did not show significant differences in the patterns of gene expression from saline injected or normal controls.
Results
Seven of the TT-injected rats died of generalized seizures 4-11 days after the injection and were excluded. Fifteen of the other 17 rats injected with TT showed seizures after a latent period of 4-13 days. The two remaining rats, perfused 7 days after injection, showed no seizure activity. The most frequently observed signs of focal seizures consisted of transient repetitive f licking movements of the contralateral forelimb accompanied by hiccup-like respiration. Seizure activity tended to be more severe in the first 2-3 days after onset. Only one of the rats was observed having a stage 5 seizure (rearing and falling; Racine, 1972) . None of the control rats showed signs of seizure activity.
As reported previously, no cell loss or disorganization of cortical lamination at the TT injection site could be detected .
In normal control rats, the granule cell layer of the dentate gyrus, the pyramidal cell layer of field CA2-CA3 of the hippocampus, layer II of the piriform cortex and the claustrum showed higher levels of BDNF mRNA than other regions or layers, in accordance with previous descriptions in rodents (Ernfors et al., 1990; Phillips et al., 1990) . In the neocortex, layers II, III and VI showed higher levels of BDNF mRNA than other layers (Fig. 1) . Saline-injected controls exhibited no detectable difference in distribution patterns of BDNF mRNA from normal controls.
All seven TT-injected rats in the 14 day survival group had seizures after a latent period of 5-13 days and showed markedly increased BDNF mRNA levels in a focal cortical area at the injection site. Typically, the medial two-thirds to four-fifths of the focus of BDNF up-regulation were located in the agranular cortex and the lateral one-third to one-fifth invaded the granular somatosensory cortex. BDNF up-regulation was most prominent in layer II and upper layer III, but was also obvious in deep layer V and upper layer VI. Layer I showed no detectable changes, in comparison with the same layer in neighboring cortical areas or with layer I of the motor cortex on the contralateral side (Figs 2, 3B-E and 4A-E). Deep layer III/layer IV and upper layer V showed less pronounced increases in BDNF mRNA levels than other layers and therefore divided the focus of up-regulation into two tiers of dense labeling, an upper one formed by layer II and upper layer III, and a lower one formed by lower layer V and upper layer VI (Figs 2, 3B-D and 4A-C). Deep layer VI, which usually did not show any up-regulation of BDNF mRNA, limited Autoradiograms showing in situ hybridization histochemistry for BDNF mRNA in a TT-injected rat brain. The rat was perfused 14 days after TT injection (35 ng) and subsequent to onset of seizures. In (B), the injection site is visible (arrow). BDNF is markedly up-regulated in a cortical focus around the site of TT injection, and down-regulated in a cortical zone surrounding this focus. In sections 970 µm anterior (A) or posterior (C) to the injection site, the up-and down-regulation of BDNF mRNA is continued. Note lack of BDNF up-regulation in deep layer III or layer IV. Scale bar = 1.0 mm.
the focus on its deep side (see below). The up-regulated cortical focus was more extensive in layers II and III, in both the mediolateral and anteroposterior directions, than in layers V and VI ( Figs 3B-E and 4A-D) . The mediolateral extent of the focus of up-regulation ranged in different animals from 1.55 to 3.09 mm in layer II and from 1.22 to 2.34 mm in upper layer VI. The areal extent of the up-regulated focus on frontal sections around the center of the TT injection varied from 1.20 to 3.81 mm 2 in different animals.
Quantification indicated that relative mRNA levels in layer II and upper layer III of the focus were, at least, 281.99 ± 118.15% (mean ± SD, range: 110-515%, n = 7) of those in the homotopic motor cortex of the contralateral side (Fig. 5) . Paired Student's t-test showed a highly significant difference (P < 0.01). The Autoradiograms from a rat injected with 25 ng TT and perfused 14 days later after onset of seizures. BDNF mRNA levels were significantly up-regulated in both the TT-injected motor cortex (B-E) and in a cortical area corresponding to the second somatosensory cortex (SII, E,F). In a cortical zone surrounding the focus of BDNF up-regulation in the motor cortex, BDNF mRNA levels were markedly down-regulated (A-E). The decreases in BDNF mRNA levels in this zone can be especially appreciated in sections located at the anterior and posterior aspects of the focus of BDNF up-regulation (A and E). The focus of BDNF up-regulation in SII (F) was not accompanied by clear reciprocal changes in the surrounding cortex. Frontal sections (A)-(E) are arranged in anteroposterior sequence and are ~950 µm apart. Framed areas (1-6) in (B)-(E) are shown at higher magnification in actual increase could be much higher as the autoradiogram at the focus of up-regulation was often saturated before other cortical areas were fully exposed (Figs 2-4) .
BDNF mRNA levels were markedly decreased in a zone of cortex surrounding the focus of up-regulation at the TT injection site (Figs 2 and 3 ). This zone of down-regulation typically included a thin ring of cortex around the focus of up-regulation and a deep stratum formed by deep layer VI under the focus. The ring appeared wider in layers II and III than in layers V and VI and usually did not extend beyond the frontal and the adjacent parietal cortical areas (Fig. 3A-E) , but in one rat it extended medially into the cingulate cortex. The thickness of the ring varied in different directions and in layer II measured 0.34-1.45 mm in different animals. Densitometr y indicated that mRNA levels in the ring-like surround dropped, on average, to 83.89 ± 6.34% (range: 69.47-93.90%, n = 7) of those of the contralateral motor cortex (Fig. 5) . The decreases were statistically significant (paired Student's t-test, P < 0.05). The control animals did not show any significant differences in BDNF mRNA levels between the two sides (Fig. 5) .
Two TT-injected rats in the 2 week survival group and with seizures, in addition to an enhanced focus at the injection site, showed up-regulation of BDNF mRNA levels in a localized focus in a region of cortex corresponding in position to somatosensory area II (SII) on the side ipsilateral to the injection. The increases in SII were mainly restricted to cortical layers II and III and the focus measured 1.01 and 2.37 mm in diameter in the two animals. The mRNA levels in layer II of SII in these animals were 174.02 and 255.28% of those in the homotopic cortical area on the contralateral side. This secondary focus of up-regulation also differed from the primary focus in the motor cortex in that it had no surrounding ring of reciprocal down-regulation (Figs 3E,F and 4F).
The contralateral motor cortex showed slight down-regulation of BDNF mRNA levels in layers II and III in some of the rats, but when quantified the visual changes did not reach statistical significance in comparison with neighboring cortical areas.
In contrast to rats of the 14 day survival group, rats of the 5-7 day sur vival group showed more variable changes in BDNF mRNA expression in the cortex. Two rats which did not show seizure signs before being perfused on postoperative day 7 had no detectable changes in BDNF mRNA levels in any part of the cerebral cortex. Two others, that were perfused within 1 h following the appearance of seizure signs on postoperative day 5 or 7, had only marginal increases in BDNF mRNA levels in layer II of the TT-injected motor cortex. The remaining six rats in the 5-7 day survival group had seizures starting 1-3 days before being perfused. They demonstrated clear increases in BDNF mRNA levels in the cerebral cortex, but the areal extent of the increases varied considerably. Three showed increases in BDNF mRNA levels over most of the frontal cortex and one in the TT-injected motor cortex only (Fig. 6A-C) . In the fifth rat, up-regulation involved all neocortical areas other than the retrosplenial cortex on the TT injected side (Fig. 6F) . In the sixth rat, which was observed having a stage 5 seizure 10 h before being perfused on postoperative day 7, the widespread upregulation involved, in addition, the contralateral neocortex, the piriform and entorhinal areas and the granule cell layers of the dentate gyri bilaterally, but fields CA1-CA3 of the hippocampus displayed no obvious alterations in BDNF mRNA distribution on either side (Figs 6E and 7) . In contrast to the up-regulation in both superficial and deep layers in rats of the 14 day survival group, increases in BDNF mRNA in rats of the 5-7 day survival group were distributed mainly in cortical layers II and III (Fig. 6) . The injected motor cortex in the first five of the six rats had mRNA levels 188.66 ± 58.07% (range: 128.85-289.60%) greater than those (layers II and III) of the contralateral side (Fig. 5) . One of these rats that showed BDNF mRNA increases in the frontal cortex also had a focus of BDNF mRNA up-regulation in layers II-III of the ipsilateral SII (Fig. 6D) .
As reported by others (Ernfors et al., 1990) , NGF and NT-3 mRNA levels in the normal neocortex are low (not shown), in comparison with their levels in the hippocampus (Fig. 8) . No changes were observed in either NGF or NT-3 mRNA levels in neocortex or hippocampus in any of the rats injected with TT (Fig. 8) .
Discussion
The present results demonstrated stage-dependent and regionspecific changes in BDNF gene expression in TT-induced epilepsy of the neocortex. Changes in BDNF expression in epileptic rats of the 5-7 day survival group are characterized by their broader distribution across large cortical areas. This agrees with previous reports showing a transient and widespread up-regulation of BDNF gene expression in various models of acute epilepsy (Ernfors et al., 1991; Isackson et al., 1991; Dugich-Djordjevic et al., 1992; Rocamora et al., 1992; Humpel et al., 1993; Schmidt-Kastner et al., 1996) . In epileptic rats of the 14 day survival group, however, up-regulation of BDNF mRNA was restricted to the TT-injected motor cortex and in the interconnected somatosensory area II, and clear down-regulation of BDNF gene expression was consistently observed in the cortical zone surrounding the BDNF up-regulated focus at the injection site. These results suggest that transition from the acute to chronic stages of TT-induced epilepsy is accompanied by the areal restriction of up-regulation to the epileptic focus and by the appearance of a surrounding cortical zone that may serve to restrict seizure spread, but simultaneously facilitate the persistence of focal epilepsy. In the seven TT-injected epileptic rats of the 14 day survival group, marked up-regulation of BDNF mRNA gene expression was seen in both the superficial (II/III) and deep layers (V/VI) of the motor cortex on the side of TT injection. In addition, a cortical zone (snd) surrounding the focus of BDNF up-regulation showed significant decreases in BDNF mRNA levels. (C) In saline-injected control animals (n = 8), no significant differences were found in BDNF mRNA levels between the injected motor cortex and the homotopic area on the contralateral side. *P < 0.05 (Student's paired t-test).
Seizure-dependent Up-regulation of BDNF
The variation of BDNF mRNA levels in animals of the two sur vival groups ver y likely ref lects the process of seizure development. After TT injection, there was a latent period of 4-13 days before the onset of behavioral seizures. The lack of changes in some animals of the 5-7 day survival group is correlated with the fact that they were perfused before or very shortly after the onset of the first behavioral seizure. No attempt was made, however, to relate variations in the results to number or severity of seizures in individual rats. The wide areal extent of changes in most rats of the short-term sur vival group was consistent with the behavioral obser vations as well as with previous reports showing that seizures tend to be more severe and spread more readily in the first few days after onset (Mellanby et al., 1977) . Although neuronal epileptiform activity has been recorded as early as 18 h after TT injection (Brener et In a rat that received 35 ng TT and was observed having a stage 5 seizure 10 h before being perfused on postoperative day 7, BDNF mRNA levels in the brain were bilaterally increased throughout most cerebral cortical areas, including the piriform cortex, but the increases were restricted to cells in superficial cortical layers. As can be seen in Figure 7 , this rat also showed markedly increased BDNF mRNA levels in the dentate gyri bilaterally, but not in Ammon's horn. Arrow indicates the injection site. (F) In a rat injected with 35 ng TT and perfused on postoperative day 7 after onset of seizures, BDNF mRNA levels were increased in most neocortical areas on the TT injected side. Scale bars = 1.0 mm.
al., 1990; Empson et al., 1993) , up-regulation of BDNF gene expression did not occur before the onset of behavioral seizures. Hence, only prolonged and synchronized hyperactivity of a very large population of neurons leads to lasting, significant changes in expression of BDNF and other genes.
Propagation of Epileptiform Activity
The localized changes in SII, which is interconnected with the TT-injected motor cortex (Carvell and Simons, 1987; Rouiller et al., 1993) , indicate that seizure activity emanating from a epileptic focus can propagate along ipsilateral corticocortical pathways. By contrast, although epileptiform activity has been recorded in the homotopic area on the side contralateral to an injection of TT (Brener et al., 1990; Empson et al., 1993) , the present study did not detect BDNF up-regulation in the motor cortex contralateral to the TT-injected motor cortex in any rats of the 14 day survival group nor in most rats of the 5-7 day survival group. This result is consistent with our previous observations of altered expression patterns of genes involved in GABAergic and glutamatergic neural transmission in the same model of epilepsy and suggests that callosal activation is insufficient to affect gene expression. It remains possible that slight changes in contralateral expression did occur but were below the threshold for detection with the methods used. Any such changes would be infinitesimally small in comparison with the ipsilateral changes.
Transition from Acute to Chronic Epilepsy
The localized changes in BDNF gene expression in rats of the 14 day survival group are likely to indicate that seizure activity had become confined to a focal cortical area by this time. This may ref lect the transition of TT-induced seizures from an acute to a chronic stage.
The appearance of a surround in which BDNF mRNA was down-regulated in rats perfused 14 days after injection is particularly interesting and probably indicates the engagement of GABAergic inhibition in confining the seizure activity to a focal area in the injected motor cortex. The likelihood that GA BAergic inhibition is increased in the cortical surround is supported by the electrophysiological demonstration of an inhibitory surround around penicillin-induced epileptic foci in the neocortex (Prince and Wilder, 1967) , although this was more extensive than the surround demonstrated in the present study, perhaps ref lecting the differential sensitivity of the techniques used in the two investigations. BDNF gene expression in hippocampal cells in vitro can be down-regulated by elevated GABAergic inhibition mediated by GABA A receptors (Zafra et al., 1991 (Zafra et al., , 1992 Berninger et al., 1995) . However, increased inhibition in the surround is unlikely to be exerted primarily by GA BAergic neurons located in the surround itself, as results reported elsewhere show that glutamic acid decarboxylase mRNA levels in the surround are actually decreased . Instead, elevated GA BAergic inhibition in the surround is likely to be carried to the surround from the hyperactive central focus because this focus shows up-regulation of glutamic acid decarboxylase mRNA levels . Decreased lateral inhibition carried in the reverse direction from the surround to the focus might, by further enhancing activity in the epileptic focus, contribute to the up-regulation of BDNF mRNA levels in the focus, as well as to the persistence of hyperexcitability in the focus. The most likely anatomical substrate for mediating lateral inhibition of this type consists of the GABAergic, large basket cells whose axons run horizontally in the neocortex for a considerable distance (1-2.5 mm) before terminating on cell bodies and proximal dendrites of other neurons (Jones and Hendry, 1984; Kawaguchi, 1995) . Diffusible factors might also contribute (Dawson and Snyder, 1994; Schuman and Madison, 1994) . It is unlikely that the decrease in BDNF mRNA levels in the surround is caused by cell death because there is no apparent cell loss in TT-induced epilepsy (Kessler and Markowitsch, 1983; Jefferys et al., 1992) . mRNA levels for the N-methyl-D-aspartate (NMDA) receptor subunit, NR1, are also up-regulated in the hyperactive TTinduced focus . This may contribute to the up-regulation of BDNF gene expression since, in hippocampal cells in vitro, increased BDNF expression has been shown to be mainly mediated by elevated glutamatergic excitation via both NMDA and non-NMDA receptors (Zafra et al., 1991 (Zafra et al., , 1992 .
The present study, in showing that BDNF mRNA was upregulated in a seizure-dependent manner in the neocortex, is in line with previous studies in the limbic system (Ernfors et al., 1991; Isackson et al., 1991; Dugich-Djordjevic et al., 1992; Rocamora et al., 1992; Humpel et al., 1993; Schmidt-Kastner et al., 1996) . The present results, however, differ from studies on limbic seizures in several respects: in the present case, NGF mRNA did not show significant changes, whereas it is markedly up-regulated in limbic models of epilepsy (Gall and Isackson, 1989; Ernfors et al., 1991; Rocamora et al.5D, 1992; Lauterborn et al., 1994; Schmidt-Kastner et al., 1996) . The fact that TT induces chronic recurrent focal seizures lasting for days or weeks instead of only for hours may be the key to this difference. In vitro induction of long-term potentiation (LTP) in the hippocampus also increases BDNF mRNA levels without affecting NGF mRNA (Patterson et al., 1992) . The present study showed an initial widespread up-regulation of BDNF mRNA on the injected side in the first few days after seizure onset and this resembles the effect of limbic seizures, but in the case of the TT model, the effect evolves to a focal one associated with reciprocal alterations in the focus and surround. These are undoubtedly seizure-dependent manifestations of the process by which a chronic epileptic focus normally develops.
BDNF and Long-term Neural Plasticity in Chronic Epilepsy
Neurons of layers II-III and V-V I are those which show up-regulation of BDNF in the epileptic focus and cells in these locations will include a majority of pyramidal cells, which are the sources of corticocortical projections, such as those to SII, and of projections to subcortical sites. They also provide, via their intracortical collaterals, the major sources of intracortical excitatory connections. BDNF expression commences in these cells in fetal life during the period when the cells are forming their synaptic connections, and BDNF expression persists normally in them into adulthood (Huntley et al., 1992) . The synaptic targets of these cells include layer IV neurons whose growth is sensitive to endogenous BDNF (McA llister et al., 1997) . Local infusion of BDNF into the visual cortex in kittens during the critical period prevents the formation of ocular dominance columns (Cabelli et al., 1995) , presumably by preventing activity-dependent withdrawal of axon branches from inappropriate columns. Thus, it is interesting that spontaneous epileptiform activity in layer V neurons of undercut slabs of rat cortex is associated with substantial sprouting of the intracortical collateral axons of these cells, with increased numbers of boutons (Salin et al., 1995) , and epileptiform activity in the focus appears to be maintained by factors other than disinhibition (Hoffman et al., 1994) . If increased levels of BDNF induced by TT are responsible for inducing this sprouting, the result is obviously a maladaptive one in adults and may contribute to maintenance of an epileptic focus.
Evidence that BDNF plays an important role in neural plasticity comes from a number of sources. BDNF knockout mice show a reduced capacity for induction of LTP or for limbic epilepsy (Kokaia et al., 1995; Korte et al., 1995) . Addition of exogenous BDNF to the brain of BDNF-deficient mutant mice restores this capacity (Patterson et al., 1996) . Administration of BDNF to the hippocampus or visual cortex of normal animals enhances synaptic efficacy and release of glutamate (Lessmann et Kang and Schuman, 1995; Carmignoto et al., 1997) . Therefore, the reciprocal increases and decreases in BDNF mRNA in the TT injection focus and the surround may also contribute to long-term changes in neuronal excitability and in neuronal structure which may accompany chronic epilepsy. The increased BDNF gene expression may also serve a protective role in minimizing cell death due to excitotoxicity in epilepsy.
